Lotus Pharmaceutical Co., Ltd.

Rachunek Zysków i Strat





Przychody TTM (mln): 17 594
EBIT TTM (mln): 5 795
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Rok finansowy 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 607 590 532 503 658 2,310 5,522 5,903 6,424 6,429 9,175 10,729 12,649 14,633 16,958 18,584
Przychód Δ r/r 0.0% -2.7% -9.8% -5.5% 30.9% 250.8% 139.0% 6.9% 8.8% 0.1% 42.7% 16.9% 17.9% 15.7% 15.9% 9.6%
Marża brutto 59.1% 60.1% 61.5% 54.6% 62.1% 50.0% 58.5% 56.4% 47.9% 48.8% 46.3% 42.8% 44.6% 53.3% 49.2% 58.8%
EBIT (mln) 40 23 -146 -203 -25 -435 449 244 523 449 1,216 1,637 2,201 4,319 4,903 6,017
EBIT Δ r/r 0.0% -43.6% -740.8% 39.4% -87.6% 1621.0% -203.1% -45.6% 114.0% -14.2% 170.9% 34.7% 34.4% 96.2% 13.5% 22.7%
EBIT (%) 6.7% 3.9% -27.4% -40.4% -3.8% -18.8% 8.1% 4.1% 8.1% 7.0% 13.3% 15.3% 17.4% 29.5% 28.9% 32.4%
Koszty finansowe (mln) 1 4 9 10 6 87 360 278 260 320 339 334 297 382 557 571
EBITDA (mln) 52 68 -35 -112 99 -337 961 604 833 875 1,802 2,347 2,960 5,256 6,114 8,214
EBITDA(%) 8.6% 11.5% -6.5% -22.3% 15.0% -14.6% 17.4% 10.2% 13.0% 13.6% 19.6% 21.9% 23.4% 35.9% 36.1% 44.2%
Podatek (mln) 22 20 6 -16 10 -43 144 112 162 40 198 275 467 919 997 1,294
Zysk Netto (mln) 3 15 -38 -193 12 -442 104 -134 8 99 663 1,027 1,403 3,021 4,106 5,066
Zysk netto Δ r/r 0.0% 382.9% -355.2% 403.2% -106.1% -3821.0% -123.5% -228.9% -105.7% 1194.4% 566.3% 54.9% 36.7% 115.3% 35.9% 23.4%
Zysk netto (%) 0.5% 2.6% -7.2% -38.4% 1.8% -19.1% 1.9% -2.3% 0.1% 1.5% 7.2% 9.6% 11.1% 20.6% 24.2% 27.3%
EPS 0.0824 0.31 -0.82 -4.33 -0.94 -2.41 0.44 -0.56 0.09 0.42 3.11 4.23 5.5 11.59 15.72 19.35
EPS (rozwodnione) 0.0824 0.31 -0.82 -4.33 -0.94 -2.41 0.44 -0.56 0.09 0.42 3.11 4.23 5.47 11.54 15.67 19.26
Ilośc akcji (mln) 41 48 47 45 151 183 238 238 238 238 242 243 255 261 261 262
Ważona ilośc akcji (mln) 41 48 47 45 151 183 238 238 238 238 242 243 257 262 262 263
Waluta TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD